Expert Insight View All

A patient-centered approach to optimizing T2D management with health-related quality of life in mind

According to the American Diabetes Association (ADA)/ European Association for the Study of Diabetes (EASD) guideline, a patient-centered approach to type 2 diabetes (T2D) management should be adopted with the goal of not only preventing complications but also optimizing patients’ quality of life.1 To achieve these goals, factors that affect health-related quality of life (HRQoL) such as social determinants of health, psychosocial well-being, and health behaviors are key considerations in glycemic management strategies for patients with T2D.1 At the EASD Annual Meeting 2023, Professor Chan, Chung-Ngor Juliana from the Department of Medicine and Therapeutics, The Chinese University of Hong Kong presented the results of a cross-sectional analysis of HRQoL in patients with T2D treated with oral glucose-lowering drugs (OGLDs) who were enrolled in the Joint Asia Diabetes Evaluation (JADE) Register. In a subsequent interview with Omnihealth Practice, Prof. Chan shared further insights on the application of the JADE® Program, shedding light on the dynamics between glycemic management strategies and patients’ HRQoL.

thumb

Professor Chan, Chung-Ngor Juliana

Professor of Medicine and Therapeutics,
Head of Division of Clinical Pharmacology,
Department of Medicine and Therapeutics,
The Chinese University of Hong Kong,
Prince of Wales Hospital,
Hong Kong

CONFERENCE UPDATE View All
NEWS & PERSPECTIVE View All
Every update. In your inbox.
Get access to our exclusive articles.
Research Spotlight View All

Exploring the association of systemic glucocorticoids and incident major adverse cardiovascular events in patients with rheumatoid arthritis based on real-world data

Despite their exceptional anti-inflammatory properties, the use of systemic glucocorticoids (GCs) for the treatment of rheumatoid arthritis (RA) remains controversial due to the potential side effects, particularly their role in elevating patients’ risk of cardiovascular (CV) events. A po

03 Jan 2024
thumb

Dr. So, Ho

Assistant Professor,
Division of Rheumatology,
Department of Medicine and Therapeutics,
Faculty of Medicine,
The Chinese University of Hong Kong

Ann Rheum Dis. 2023.

So H, Lam TO (co-first author), Meng H, Lam SHM, Tam LS. Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study. Ann Rheum Dis. 2023;82(11):1387-1393.

Meeting Highlight View All

Beyond transfusion - The emerging role of luspatercept in transfusion-dependent β-thalassemia

05 Mar 2024

Transforming MCL care: The potential role of BTKi-based regimens in front-line treatment

06 Sep 2023
thumb

Professor Simon Rule

Professor of Clinical Hematology,
Plymouth University Medical School,
United Kingdom
Global Clinical Head Acalabrutinib,
Haematology R&D,
AstraZeneca

thumb

Dr. Liu, Sung-Yu Herman

Specialist in Hematology and Hematological Oncology

Infographics

Real-world effectiveness of fremanezumab in migraine prevention

08 Apr 2024

Incidence of anemia with long-term low-dose aspirin

18 Mar 2024

Decoding the spectrum of tolerance in fish allergies

04 Jan 2024

Earlier and higher risk of CVD with a younger T2D diagnosis

04 Jan 2024

U-shaped relationship between sleep duration and T2DM regardless of traditional lifestyle risk factors

17 Nov 2023

Brain Gliosis: A Potential Origin of Persistent Post-COVID-19 Depressive and Cognitive Symptoms

17 Nov 2023

The nuanced link between prediabetes and dementia

23 Aug 2023

Connecting the dots between Parkinson’s disease and rheumatoid arthritis

12 Jul 2023

Cardio-oncology monitoring in pediatric populations - Delphi consensus recommendations from an Australian and New Zealand expert group

28 Apr 2023

Targeting TSLP for severe asthma - Tezepelumab updates from the 2023 American Academy of Allergy Asthma & Immunology Annual Meeting

06 Apr 2023

A new way out for alpha thalassemia major - Give them a chance at life with In-utero transfusions

15 Mar 2023

Beware of overlapping phenotypes in severe asthma: The eosinophilia and IgE double whammy

27 Feb 2023

Stay on the path of treatment - Take on a high-K with ease
ASN abstract highlight on sodium zirconium cyclosilicate and hyperkalemia

23 Feb 2023

Real-world effectiveness of benralizumab around the globe

06 Dec 2022

Remission is within reach - Target the underlying drivers of inflammation with benralizumab

19 Sep 2022

PACIFIC-6: Durvalumab after CRT showed similar safety profile as the PACIFIC regimen with encouraging efficacy data in frailer and older patients with stage 3, unresectable NSCLC

23 Jun 2022

Caution: The risk of severe hypoglycemia is elevated in diabetic adults with NAFLD

30 May 2022

Fiber-rich diet associated with better response to immunotherapy in patients with melanoma

25 Feb 2022

Sleep disturbance may raise the odds of certain cancers but reduce the others

10 Jan 2022

Poorer survival outcomes in breast cancer patients with chronic stress

29 Oct 2021

Infant gut microbiota is associated with an increased risk of food allergies

24 Sep 2021

Depression associated with a rapid loss in kidney function

08 Jul 2021

Potential risk factors for developing nerve damage after cancer treatment

12 May 2021

Urine test to identify and verify a patient’s type of asthma

27 Feb 2021

Potential new pinprick blood test for diagnosing HPV related-cancers

31 Dec 2020

Strategy to prevent and control NCDs in Hong Kong by 2025

30 Aug 2019

Prevalence of helicobacter pylori in symptomatic children

28 Oct 2019

Heat and gut microbiota promotes stronger bones

29 Oct 2020

A potential tumor marker for cervical cancer

31 Aug 2020

No response to exercise? The gut microbiota is to blame

29 Feb 2020

Hong Kong cancer strategy: a fight against cancer

30 Dec 2019

Clinical characteristics of the hidden carriers of COVID-19

30 Apr 2020

The use of e-cigarette or vaping products is associated with an outbreak of lung injury

29 Jun 2020